Calgary-developed wound treatment used on the battlefield in Ukraine
Calgary-based NanoTess received Health Canada approval for its NanoSALV Catalytic in 2022 and evaluated it by treating unhoused populations in encampments.
A Calgary-developed wound treatment, NanoSALV Catalytic, is now being used by military forces in Ukraine, according to a report. The treatment, initially funded by Canada’s Department of National Defence, has been used on 6,000 wounded soldiers and civilians. NanoTess, a Calgary-based company, received Health Canada approval for the gel in 2022 and has since been trialed in unhoused populations.
The treatment, which uses nanomaterials to speed up the body's natural healing process, can be applied by people with limited medical training, making it ideal for use in the battlefield. NanoSALV has been praised for its ability to lower the energy required for healing, fight germs and infection-causing micro-organisms, and buy time on the battlefield.
Clinical pharmacist Hailie Uren, with the Ukrainian Ministry of Health, said the treatment can be applied and go to work when there's only one nurse to care for up to 90 patients. Surgeon Dr. Eric Fung also highlighted the treatment's ability to reduce strain on the medical system in mass casualty events.
Written by urgent.news from Global News's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
This story
This is one outlet's version. Read the fullest account.
